Skip to main content
. 2021 May 7;20:99. doi: 10.1186/s12933-021-01286-7

Fig. 6.

Fig. 6

Schematic representation of the proposed effect of diabetes milieu on ACE2 in the heart of patients with type 2 diabetes. In patients with diabetes, the enhanced long-term non-enzymatic glycation of ACE2 at the neck domain of dimerization can affect ACE2 oligomerization and, consequently, its avidity for SARS-COV-2 Spike binding, potentially favoring cardiomyocyte virus entry